the risk of transmission of vCJD and other forms of human prion disease through blood transfusion." The Pall Leukotrap® Affinity Prion Reduction Filter System reduces both leukocytes and ...

Pall Corporation (PLL) announced it has entered into an agreement to sell certain assets of its blood collection, filtration and processing product lines to Haemonetics Corporation (HAE ...

Pall's leukoreduction filters are the global standard of care for transfusion medicine. Roberto Perez, President, Pall Life Sciences added, “Our goal is to help blood centers and hospitals ...

Pall Corp.'s decision to sell some of its blood and transfusion assets, for $550 million, marks a shift in strategy for the global filtration maker during its first year under a new chief ...

Pall is selling certain assets of its blood collection, filtration, and processing product lines to Haemonetics for roughly $550 million. The transaction includes related systems as well as ...

Haemonetics Corporation,a global healthcare company, has entered into a definitive agreement to acquire the business assets of the blood collection, filtration and processing product lines of Pall ...

Pall has exclusive global sales and marketing ... Several countries have mandated routine blood filtration as a matter of public policy. NetSat Express, a provider of Internet services via ...

PORT WASHINGTON, N.Y. (AP) -- Filtration equipment manufacturer Pall Corp. has agreed to sell certain operations and equipment used in blood transfusions to health care company Haemonetics Corp.